Salvinorin A content in legal high products of Salvia divinorum sold in Mexico.
Rafael Hernández-bello, Rosa Virginia García-rodríguez, Karlina García-sosa, Luis Manuel Peña-rodríguez, Maribel Vázquez-hernández, Fernando Rafael Ramos-Morales, Olivia Corcoran, Alberto Sánchez-medina
Forensic Science International April 1, 2015 DOI: 10.1016/j.forsciint.2015.01.038 (opens in new tab)
Study at a glance
AI-extracted from the abstract| Characteristics | Quantitative analysis Peer reviewed |
|---|---|
| Population | Commercial Salvia divinorum products sold in Mexico |
| Topics | Salvia divinorum |
| Keywords | Drug abuse Hplc method Legal highs Quantified Variability High-strength products Health risk Product regulation regulation Declared potency Misrepresent |
| Citations | 19 |
| Key points | Salvinorin A content varied widely among brands and did not always match declared potency, indicating a lack of regulation and potential health risk. |
Abstract
Salvia divinorum (Lamiaceae) is a herb native to Mexico where it is used by Mazatec shamans for spiritual and divination purposes. S. divinorum products are easily available to consumers and are used worldwide as legal highs because of the hallucinogenic effects caused mainly by salvinorin A. Highly popular videos and websites on the internet depicting the use of S. divinorum products have contributed to an increase in their consumption. Recent reports have highlighted the potential of these products to induce psychosis in consumers. In Mexico, dried leaf extracts of S. divinorum are sold in different strengths, claiming to correlate with increasing amounts of salvinorin A. In order to determine the variability of salvinorin A content between brands and to investigate possible correlation between brand strengths, this study sought to quantify salvinorin A in commercial products available in Mexico using an HPLC method. The HPLC analytical method showed a correlation coefficient R(2)>0.99, with LOD of 0.44 μg/mL and LOQ of 1.34 μg/mL. The retention time for salvinorin A was 23.09±0.95 min and the measured concentrations ranged between 8.32±0.65 and 56.52±3.77 mg/g dried leaf. The results for brand c did not show an agreement between the declared and the calculated amount of salvinorin A. Additionally, the emergence in Mexico of high strength salvia products (100×), the lack of regulation and the observed variability of salvinorin A content between brands of commercial legal highs products of S. divinorum could result in a health problem for consumers.
Citations in the library
Cited by 9
- A unique natural selective kappa-opioid receptor agonist, salvinorin A, and its roles in human therapeutics. Phytochemistry May 1, 2017
- Pharmacokinetics and Pharmacodynamics of Salvinorin A and Salvia divinorum: Clinical and Forensic Aspects Pharmaceuticals February 3, 2021
- Salvia divinorum: from recreational hallucinogenic use to analgesic and anti-inflammatory action. Journal of Pain Research 2019
- DARK Classics in Chemical Neuroscience: Salvinorin A. ACS Chemical Neuroscience December 2, 2020
- The enchanted snake and the forbidden fruit: the ayahuasca ‘fairy tale’ tourist Journal of Marketing Management April 16, 2019
and 4 more in the library
Cites 28
- Here today, gone tomorrow…and back again? A review of herbal marijuana alternatives (K2, Spice), synthetic cathinones (bath salts), kratom, Salvia divinorum, methoxetamine, and piperazines. Journal of Medical Toxicology March 1, 2012
- Salvinorin, a new trans-neoclerodane diterpene from Salvia divinorum(Labiatae) Journal of the Chemical Society Perkin Transactions 1 1982
- Opioid receptors and legal highs:Salvia divinorumand Kratom Clinical Toxicology 2008
- Divinorin A, a psychotropic terpenoid, and divinorin B from the hallucinogenic Mexican mint, Salvia divinorum The Journal of Organic Chemistry November 1, 1984
- Potential anxiolytic‐ and antidepressant‐like effects of salvinorin A, the main active ingredient of Salvia divinorum, in rodents British Journal of Pharmacology May 5, 2009
and 23 more in the library